Adrian Schreiber (A Schreiber)

ORCID

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 14

Top Venues

Annals of the rheumatic diseases

RMD open

Journal of the American Society of Nephrology : JASN

BMC nephrology

This page only lists publications with an associated author ORCID identifier.

Publications

Dörte Lodka, Maria Zschummel, Mario Bunse, Anthony Rousselle, Janis Sonnemann, Ralph Kettritz, Uta E Höpken, Adrian Schreiber
CD19-targeting CAR T cells protect from ANCA-induced acute kidney injury. Annals of the rheumatic diseases 83 (4) (2024)
Dörte Lodka, Maria Zschummel, Mario Bunse, Anthony Rousselle, Janis Sonnemann, Ralph Kettritz, Uta E Höpken, Adrian Schreiber
CD19-targeting CAR T cells protect from ANCA-induced acute kidney injury. Annals of the rheumatic diseases 83 (4) (2024)
Luka Prskalo, Adrian Schreiber, Philipp Enghard
Authors' Reply: Utility of Urinary CD4+ T-Cell Count in Detecting ANCA-Associated Vasculitis Renal Relapse. Journal of the American Society of Nephrology : JASN (2024)
Dörte Lodka, Maria Zschummel, Mario Bunse, Anthony Rousselle, Janis Sonnemann, Ralph Kettritz, Uta E Höpken, Adrian Schreiber
CD19-targeting CAR T cells protect from ANCA-induced acute kidney injury. Annals of the rheumatic diseases 83 (4) (2024)
Dörte Lodka, Maria Zschummel, Mario Bunse, Anthony Rousselle, Janis Sonnemann, Ralph Kettritz, Uta E Höpken, Adrian Schreiber
CD19-targeting CAR T cells protect from ANCA-induced acute kidney injury. Annals of the rheumatic diseases (2024)
Dörte Lodka, Maria Zschummel, Mario Bunse, Anthony Rousselle, Janis Sonnemann, Ralph Kettritz, Uta E Höpken, Adrian Schreiber
CD19-targeting CAR T cells protect from ANCA-induced acute kidney injury. Annals of the rheumatic diseases 83 (4) (2024)
Lennard Ostendorf, Marie Burns, Dimitrios Laurin Wagner, Philipp Enghard, Kerstin Amann, Henrik Mei, Kai-Uwe Eckardt, Evelyn Seelow, Adrian Schreiber
Daratumumab for the treatment of refractory ANCA-associated vasculitis. RMD open 9 (1) (2023)
Lennard Ostendorf, Marie Burns, Dimitrios Laurin Wagner, Philipp Enghard, Kerstin Amann, Henrik Mei, Kai-Uwe Eckardt, Evelyn Seelow, Adrian Schreiber
Daratumumab for the treatment of refractory ANCA-associated vasculitis. RMD open 9 (1) (2023)
Lennard Ostendorf, Marie Burns, Dimitrios Laurin Wagner, Philipp Enghard, Kerstin Amann, Henrik Mei, Kai-Uwe Eckardt, Evelyn Seelow, Adrian Schreiber
Daratumumab for the treatment of refractory ANCA-associated vasculitis. RMD open 9 (1) (2023)
Lennard Ostendorf, Marie Burns, Dimitrios Laurin Wagner, Philipp Enghard, Kerstin Amann, Henrik Mei, Kai-Uwe Eckardt, Evelyn Seelow, Adrian Schreiber
Daratumumab for the treatment of refractory ANCA-associated vasculitis. RMD open 9 (1) (2023)
Lennard Ostendorf, Marie Burns, Dimitrios Laurin Wagner, Philipp Enghard, Kerstin Amann, Henrik Mei, Kai-Uwe Eckardt, Evelyn Seelow, Adrian Schreiber
Daratumumab for the treatment of refractory ANCA-associated vasculitis. RMD open 9 (1) (2023)
Ralph Kettritz, Adrian Schreiber
Complement is Complimentary in Membranous Nephropathy. Journal of the American Society of Nephrology : JASN (2022)
Anthony Rousselle, Janis Sonnemann, Kerstin Amann, Alexander Mildner, Dörte Lodka, Lovis Kling, Markus Bieringer, Udo Schneider, Achim Leutz, Philipp Enghard, Ralph Kettritz, Adrian Schreiber
CSF2-dependent monocyte education in the pathogenesis of ANCA-induced glomerulonephritis. Annals of the rheumatic diseases 81 (8) (2022)
C J Steffen, N Koch, K U Eckardt, K Amann, E Seelow, Adrian Schreiber
Hemophagocytic lymphohistiocytosis and thrombotic microangiopathy after parvovirus B19 infection and renal transplantation: a case report. BMC nephrology 22 (1) (2021)

Adrian Schreiber.css-eqlu8i{font-size:small;padding-left:4px;} (A Schreiber)

Publication Activity (10 Years)

Top Topics

Top Venues

Adrian Schreiber (A Schreiber)